Physician profile
Shawn King
NPI 1871741116
$4,117.11
in general payments reported to CMS, 2019-2025
10 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $939 · 2022: $1,159 · 2023: $909 · 2024: $627 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,018.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $2,425.99 | 2021-2025 | Embotrap, Emboguard, Cerepak Uniform |
| Penumbra, INC. | $774.53 | 2021-2022 | |
| Medtronic, INC. | $256.19 | 2021-2024 | Solitaire X, Axium Primetm |
| Rapid Medical Ltd | $181.65 | 2023 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Inari Medical, INC. | $124.98 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $107.79 | 2021-2022 | |
| Route 92 Medical, INC. | $106.84 | 2025 | |
| Microvention, INC. | $82.90 | 2022 | |
| Pfizer INC. | $35.85 | 2023 | |
| Cardiva Medical, INC. | $20.39 | 2023 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.